Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy.
about
Modeling Kidney Disease with iPS CellsG-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingFlow Cytometry: Impact on Early Drug DiscoveryDrug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation.RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model.Aberrant α-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells.Improved approach for chondrogenic differentiation of human induced pluripotent stem cells.Cellular models and therapies for age-related macular degeneration.Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac DifferentiationDiscovery of novel small molecule inhibitors of cardiac hypertrophy using high throughput, high content imaging.Common miR-590 Variant rs6971711 Present Only in African Americans Reduces miR-590 BiogenesisDrug combination therapy increases successful drug repositioning.Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line.Cell therapy worldwide: an incipient revolution.The development of high-content screening (HCS) technology and its importance to drug discovery.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.Molecular Approaches in HFpEF: MicroRNAs and iPSC-Derived Cardiomyocytes.Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial ScalesBET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.Antihypertrophic Effects of Small Molecules that Maintain Mitochondrial ATP Levels Under Hypoxia.An impedance-based cellular assay using human iPSC-derived cardiomyocytes to quantify modulators of cardiac contractility.Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.[Individualized stem cell therapy].A Cardiac Cell Outgrowth Assay for Evaluating Drug Compounds Using a Cardiac Spheroid-on-a-Chip Device.Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits
P2860
Q26770384-4299800F-DD16-4B25-85B0-055A63A4592BQ26772221-6C87C3E7-CD00-497B-A5F2-328B1D0F72E2Q30380311-0D5F90DC-76E5-48F8-89FB-EB3CB7C0E8A5Q30846580-F74FF886-DBA6-4BE4-AAD3-ACE274548DA9Q34257330-78EAE70C-3C05-42EB-8BCD-1837CEB68C9FQ34533747-DE5E35DA-18EE-4AAB-9AEA-674F7FB54687Q35546995-239591D4-A60D-4EEF-A384-DB15D9EE2044Q35558042-EC846AA4-FB90-49D0-813A-FE76371BC4CAQ35873200-35BD0C8A-F083-499B-8D61-357B2225F57DQ36003962-F18E7B5B-5745-4140-A184-42FBEE14C793Q36917391-C920266C-AB7D-4C42-A74A-7BCD2F057A6BQ37004251-292D8E17-B96A-4766-BD15-65D57D0448D4Q37573646-339309FA-D129-42BF-A0F7-AB2F8A9FC818Q38240972-89F9557C-840A-41CA-BA7D-E613877E2023Q38391002-E1BD07F3-E191-4A9D-BE9F-478ABCE517CCQ38772165-94F74B07-C384-49E4-86A7-67D172EAF470Q38874111-AEC03BBD-702F-447E-BCE5-6D4CFAF2A79BQ39061922-324E59BB-27AF-411D-BC75-BF9E5201DFC3Q39109857-47BEA3C7-9DAE-4A58-BAD7-45220D7D3D4EQ41255959-CDC3B096-1557-419F-A1AF-CB3142B49F36Q42651346-A3EA59C4-15B1-45D4-BD81-E73543298385Q46145054-6FF6BE66-05BE-42B1-9076-4E076259E68AQ47587806-A7BF3ECC-07F0-469F-95B4-37B65E5649F6Q48752307-1CD3B05E-999F-43F5-99AB-B77432525B66Q55687817-1A6EEF92-9895-457C-9E2F-F911ACB33600Q58577756-EC34990B-3EF4-434F-989E-0861526E914E
P2860
Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Phenotypic screening with huma ...... rrogating cardiac hypertrophy.
@en
Phenotypic screening with huma ...... rrogating cardiac hypertrophy.
@nl
type
label
Phenotypic screening with huma ...... rrogating cardiac hypertrophy.
@en
Phenotypic screening with huma ...... rrogating cardiac hypertrophy.
@nl
prefLabel
Phenotypic screening with huma ...... rrogating cardiac hypertrophy.
@en
Phenotypic screening with huma ...... rrogating cardiac hypertrophy.
@nl
P2093
P2860
P356
P1476
Phenotypic screening with huma ...... rrogating cardiac hypertrophy.
@en
P2093
Arne Thompson
Blake Anson
Brad Swanson
Chad Koonce
Coby Carlson
Natsuyo Aoyama
Shannon Einhorn
Steve Fiene
Steven Kattman
P2860
P304
P356
10.1177/1087057113500812
P577
2013-09-26T00:00:00Z